Biliary Tract Cancers, Version 2.2023 Featured Updates to the NCCN Guidelines

被引：68

作者：

Benson, Al B., III ^{[1
]}

D'Angelica, Michael I. ^{[2
]}

Abrams, Thomas ^{[3
]}

Abbott, Daniel E. ^{[4
]}

Ahmed, Aijaz ^{[5
]}

Anaya, Daniel A. ^{[6
]}

Anders, Robert ^{[7
]}

Are, Chandrakanth ^{[8
]}

Bachini, Melinda ^{[9
]}

Binder, David ^{[10
]}

Borad, Mitesh ^{[11
]}

Bowlus, Christopher ^{[12
]}

Brown, Daniel ^{[13
]}

Burgoyne, Adam ^{[14
]}

Castellanos, Jason ^{[15
]}

Chahal, Prabhleen ^{[16
,17
]}

Cloyd, Jordan ^{[18
,19
]}

Covey, Anne M. ^{[2
]}

Glazer, Evan S. ^{[20
]}

Hawkins, William G. ^{[21
,22
]}

Iyer, Renuka ^{[23
]}

Jacob, Rojymon ^{[24
]}

Jennings, Lawrence ^{[1
]}

Kelley, R. Kate ^{[25
]}

Kim, Robin ^{[26
]}

Levine, Matthew ^{[27
]}

Palta, Manisha ^{[28
]}

Park, James O. ^{[29
]}

Raman, Steven ^{[30
]}

Reddy, Sanjay ^{[15
]}

Ronnekleiv-Kelly, Sean ^{[4
]}

Sahai, Vaibhav ^{[31
]}

Singh, Gagandeep ^{[32
]}

Stein, Stacey ^{[33
]}

Turk, Anita ^{[34
]}

Vauthey, Jean-Nicolas ^{[35
]}

Venook, Alan P. ^{[25
]}

Yopp, Adam ^{[36
]}

McMillian, Nicole ^{[37
]}

Schonfeld, Ryan ^{[37
]}

Hochstetler, Cindy ^{[37
]}

机构：

[1] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[2] Mem Sloan Kettering Canc Ctr, New York, NY USA

[3] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[4] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA

[5] Stanford Canc Inst, Stanford, CA USA

[6] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[7] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA

[8] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[9] Cholangiocarcinoma Fdn, Herriman, UT USA

[10] Univ Colorado, Ctr Canc, Boulder, CO 80309 USA

[11] Mayo Clin, Comprehens Canc Ctr, Rochester, MN USA

[12] Univ Calif Davis, Comprehens Canc Ctr, Davis, CA USA

[13] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[14] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA USA

[15] Fox Chase Canc Ctr, Philadelphia, PA USA

[16] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA

[17] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA

[18] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA

[19] Solove Res Inst, Columbus, OH USA

[20] Univ Tennessee, Hlth Sci Ctr, Knoxville, TN 37996 USA

[21] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[22] Washington Univ, Sch Med, St Louis, MO USA

[23] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA

[24] UAB, ONeal Comprehens Canc Ctr, Birmingham, AL USA

[25] UCSF, HelenDiller Family Comprehens Canc Ctr, San Francisco, CA USA

[26] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[27] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[28] Duke Canc Inst, Durham, NC USA

[29] Fred Hutchinson Canc Res Ctr, Seattle, WA USA

[30] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA

[31] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA

[32] City Hope Natl Med Ctr, Duarte, CA USA

[33] Yale Canc Hosp, Smilow Canc Hosp, New Haven, CT USA

[34] Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Bloomington, IN 47405 USA

[35] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[36] UT Southwestern Simmons Comprehens Canc Ctr, Dallas, TX USA

[37] Natl Comprehens Canc Network, Plymouth Meeting, PA USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2023年 / 21卷 / 07期

关键词：

POSITIVE SOLID TUMORS; OPEN-LABEL; PHASE; 1/2; FUSION; CHOLANGIOCARCINOMA; MULTICENTER; EFFICACY; CHEMOTHERAPY; CABOZANTINIB; COMBINATION;

D O I：

10.6004/jnccn.2023.0035

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate guidelines: Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for Biliary Tract Cancers provide recommendations for the evaluation and comprehensive care of patients with gallbladder cancer, intrahepatic cholangiocarcinoma, and extrahepatic cholangiocarcinoma. The multidisciplinary panel of experts meets at least on an annual basis to review requests from internal and external entities as well as to evaluate new data on current and emerging therapies. These Guidelines Insights focus on some of the recent updates to the NCCN Guidelines for Biliary Tract Cancers as well as the newly published section on principles of molecular testing.

引用

页码：695 / 704

页数：10

共 50 条

[31] B-Cell Lymphomas, Version 5.2021 Featured Updates to the NCCN Guidelines
Zelenetz, Andrew D.
Gordon, Leo I.
Chang, Julie E.
Christian, Beth
Abramson, Jeremy S.
Advani, Ranjana H.
Bartlett, Nancy L.
Budde, L. Elizabeth
Caimi, Paolo F.
De Vos, Sven
Dholaria, Bhagirathbhai
Fakhri, Bita
Fayad, Luis E.
Glenn, Martha J.
Habermann, Thomas M.
Hernandez-Ilizaliturri, Francisco
Hsi, Eric
Hu, Boyu
Kaminski, Mark S.
Kelsey, Christopher R.
Khan, Nadia
Krivacic, Susan
LaCasce, Ann S.
Lim, Megan
Narkhede, Mayur
Rabinovitch, Rachel
Ramakrishnan, Praveen
Reid, Erin
Roberts, Kenneth B.
Saeed, Hayder
Smith, Stephen D.
Svoboda, Jakub
Swinnen, Lode J.
Tuscano, Joseph
Vose, Julie M.
Dwyer, Mary A.
Sundar, Hema
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (11): : 1218 - 1230
[32] Gastrointestinal Stromal Tumors Version 2.2022 Featured Updates to the NCCN Guidelines
von Mehren, Margaret
Kane, John M.
Riedel, Richard F.
Sicklick, Jason K.
Pollack, Seth M.
Agulnik, Mark
Bui, Marilyn M.
Carr-Ascher, Janai
Choy, Edwin
Connelly, Mary
Dry, Sarah
Ganjoo, Kristen N.
Gonzalez, Ricardo J.
Holder, Ashley
Homsi, Jade
Keedy, Vicki
Kelly, Ciara M.
Kim, Edward
Liebner, David
McCarter, Martin
McGarry, Sean, V
Mesko, Nathan W.
Meyer, Christian
Pappo, Alberto S.
Parkes, Amanda M.
Petersen, Ivy A.
Poppe, Matthew
Schuetze, Scott
Shabason, Jacob
Spraker, Matthew B.
Zimel, Melissa
Bergman, Mary Anne
Sundar, Hema
Hang, Lisa E.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (11): : 1204 - 1214
[33] Acute Myeloid Leukemia, Version 2.2013 Featured Updates to the NCCN Guidelines
O'Donnell, Margaret R.
Tallman, Martin S.
Abboud, Camille N.
Altman, Jessica K.
Appelbaum, Frederick R.
Arber, Daniel A.
Attar, Eyal
Borate, Uma
Coutre, Steven E.
Damon, Lloyd E.
Lancet, Jeffrey
Maness, Lori J.
Marcucci, Guido
Martin, Michael G.
Millenson, Michael M.
Moore, Joseph O.
Ravandi, Farhad
Shami, Paul J.
Smith, B. Douglas
Stone, Richard M.
Strickland, Stephen A.
Wang, Eunice S.
Gregory, Kristina M.
Naganuma, Maoko
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (09): : 1047 - 1055
[34] Acute Myeloid Leukemia, Version 2.2021 Featured Updates to the NCCN Guidelines
Pollyea, Daniel A.
Bixby, Dale
Perl, Alexander
Bhatt, Vijaya Raj
Altman, Jessica K.
Appelbaum, Frederick R.
de Lima, Marcos
Fathi, Amir T.
Foran, James M.
Gojo, Ivana
Hall, Aric C.
Jacoby, Meagan
Lancet, Jeffrey
Mannis, Gabriel
Marcucci, Guido
Martin, Michael G.
Mims, Alice
Neff, Jadee
Nejati, Reza
Olin, Rebecca
Percival, Mary-Elizabeth
Prebet, Thomas
Przespolewski, Amanda
Rao, Dinesh
Ravandi-Kashani, Farhad
Shami, Paul J.
Stone, Richard M.
Strickland, Stephen A.
Sweet, Kendra
Vachhani, Pankit
Wieduwilt, Matthew
Gregory, Kristina M.
Ogba, Ndiya
Tallman, Martin S.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (01): : 17 - 27
[35] Non-Hodgkin's Lymphomas, Version 3.2016 Featured Updates to the NCCN Guidelines
Horwitz, Steven M.
Zelenetz, Andrew D.
Gordon, Leo I.
Wierda, William G.
Abramson, Jeremy S.
Advani, Ranjana H.
Andreadis, C. Babis
Bartlett, Nancy
Byrd, John C.
Fayad, Luis E.
Fisher, Richard I.
Glenn, Martha J.
Habermann, Thomas M.
Harris, Nancy Lee
Hernandez-Ilizaliturri, Francisco
Hoppe, Richard T.
Kaminski, Mark S.
Kelsey, Christopher R.
Kim, Youn H.
Krivacic, Susan
LaCasce, Ann S.
Lunning, Matthew
Nademanee, Auayporn
Press, Oliver
Rabinovitch, Rachel
Reddy, Nishitha
Reid, Erin
Roberts, Kenneth
Saad, Ayman A.
Sokol, Lubomir
Swinnen, Lode J.
Vose, Julie M.
Yahalom, Joachim
Zafar, Nadeem
Dwyer, Mary
Sundar, Hema
Porcu, Pierluigi
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (09): : 1067 - 1079
[36] B-Cell Lymphomas, Version 6.2023 Featured Updates to the NCCN Guidelines
Zelenetz, Andrew D.
Gordon, Leo, I
Abramson, Jeremy S.
Advani, Ranjana H.
Andreadis, Babis
Bartlett, Nancy L.
Budde, L. Elizabeth
Caimi, Paolo F.
Chang, Julie E.
Christian, Beth
DeVos, Sven
Dholaria, Bhagirathbhai
Fayad, Luis E.
Habermann, Thomas M.
Hamid, Muhammad Saad
Hernandez-Ilizaliturri, Francisco
Hu, Boyu
Kaminski, Mark S.
Karimi, Yasmin
Kelsey, Christopher R.
King, Rebecca
Krivacic, Susan
LaCasce, Ann S.
Lim, Megan
Messmer, Marcus
Narkhede, Mayur
Rabinovitch, Rachel
Ramakrishnan, Praveen
Reid, Erin
Roberts, Kenneth B.
Saeed, Hayder
Smith, Stephen D.
Svoboda, Jakub
Swinnen, Lode J.
Tuscano, Joseph
Vose, Julie M.
Dwyer, Mary A.
Sundar, Hema
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (11): : 1118 - 1131
[37] B-Cell Lymphomas, Version 3.2019 Featured Updates to the NCCN Guidelines
Zelenetz, Andrew D.
Gordon, Leo I.
Abramson, Jeremy S.
Advani, Ranjana H.
Bartlett, Nancy L.
Caimi, Paolo F.
Chang, Julie E.
Chavez, Julio C.
Christian, Beth
Fayad, Luis E.
Glenn, Martha J.
Habermann, Thomas M.
Harris, Nancy Lee
Hernandez-Ilizaliturri, Francisco
Kaminski, Mark S.
Kelsey, Christopher R.
Khan, Nadia
Krivacic, Susan
LaCasce, Ann S.
Mehta, Amitkumar
Nademanee, Auayporn
Rabinovitch, Rachel
Reddy, Nishitha
Reid, Erin
Roberts, Kenneth B.
Smith, Stephen D.
Snyder, Erin D.
Swinnen, Lode J.
Vose, Julie M.
Dwyer, Mary A.
Sundar, Hema
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (06): : 651 - 661
[38] Non-Small Cell Lung Cancer, Version 1.2020 Featured Updates to the NCCN Guidelines
Ettinger, David S.
Wood, Douglas E.
Aggarwal, Charu
Aisner, Dara L.
Akerley, Wallace
Bauman, Jessica R.
Bharat, Ankit
Bruno, Debora S.
Chang, Joe Y.
Chirieac, Lucian R.
D'Amico, Thomas A.
Dilling, Thomas J.
Dobelbower, Michael
Gettinger, Scott
Govindan, Ramaswamy
Gubens, Matthew A.
Hennon, Mark
Horn, Leora
Lackner, Rudy P.
Lanuti, Michael
Leal, Ticiana A.
Lin, Jules
Loo, Billy W., Jr.
Martins, Renato G.
Otterson, Gregory A.
Patel, Sandip P.
Reckamp, Karen L.
Riely, Gregory J.
Schild, Steven E.
Shapiro, Theresa A.
Stevenson, James
Swanson, Scott J.
Tauer, Kurt W.
Yang, Stephen C.
Gregory, Kristina
Hughes, Miranda
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (12): : 1464 - 1472
[39] NCCN Guidelines® Insights Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017 Featured Updates to the NCCN Guidelines
Wierda, William G.
Zelenetz, Andrew D.
Gordon, Leo I.
Abramson, Jeremy S.
Advani, Ranjana H.
Andreadis, C. Babis
Bartlett, Nancy
Byrd, John C.
Caimi, Paolo
Fayad, Luis E.
Fisher, Richard I.
Glenn, Martha J.
Habermann, Thomas M.
Harris, Nancy Lee
Hernandez-Ilizaliturri, Francisco
Hoppe, Richard T.
Horwitz, Steven M.
Kaminski, Mark S.
Kelsey, Christopher R.
Kim, Youn H.
Krivacic, Susan
LaCasce, Ann S.
Martin, Michael G.
Nademanee, Auayporn
Porcu, Pierluigi
Press, Oliver
Rabinovitch, Rachel
Reddy, Nishitha
Reid, Erin
Roberts, Kenneth
Saad, Ayman A.
Snyder, Erin D.
Sokol, Lubomir
Swinnen, Lode J.
Vose, Julie M.
Yahalom, Joachim
Dwyer, Mary A.
Sundar, Hema
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (03): : 293 - 311
[40] NCCN Guidelines® Insights Non- Small Cell Lung Cancer, Version 5.2018 Featured Updates to the NCCN Guidelines
Ettinger, David S.
Aisner, Dara L.
Wood, Douglas E.
Akerley, Wallace
Bauman, Jessica
Chang, Joe Y.
Chirieac, Lucian R.
D'Amico, Thomas A.
Dilling, Thomas J.
Dobelbower, Michael
Govindan, Ramaswamy
Gubens, Matthew A.
Hennon, Mark
Horn, Leora
Lackner, Rudy P.
Lanuti, Michael
Leal, Ticiana A.
Lilenbaum, Rogerio
Lin, Jules
Loo, Billy W., Jr.
Martins, Renato
Otterson, Gregory A.
Sandip, P.
Reckamp, Karen
Riely, Gregory J.
Schild, Steven E.
Shapiro, Theresa A.
Stevenson, James
Swanson, Scott J.
Tauer, Kurt
Yang, Stephen C.
Gregory, Kristina
Hughes, Miranda
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (07): : 807 - 821

← 1 2 3 4 5 →